177 related articles for article (PubMed ID: 23179366)
1. Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients.
Saito H; Takaya S; Osaki T; Ikeguchi M
Gastric Cancer; 2013 Oct; 16(4):473-9. PubMed ID: 23179366
[TBL] [Abstract][Full Text] [Related]
2. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas ligand is associated with natural killer cell dynamics in coronary artery disease.
Szymanowski A; Li W; Lundberg A; Evaldsson C; Nilsson L; Backteman K; Ernerudh J; Jonasson L
Atherosclerosis; 2014 Apr; 233(2):616-622. PubMed ID: 24534457
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble Fas ligand in patients with gastric carcinoma.
Tsutsumi S; Kuwano H; Shimura T; Morinaga N; Mochiki E; Asao T
Cancer; 2000 Dec; 89(12):2560-4. PubMed ID: 11135216
[TBL] [Abstract][Full Text] [Related]
6. Plasma soluble Fas ligand concentration: decrease in elderly men and increase in patients with gastric carcinoma.
Ichikura T; Majima T; Uchida T; Okura E; Ogawa T; Mochizuki H
Oncol Rep; 2001; 8(2):311-4. PubMed ID: 11182046
[TBL] [Abstract][Full Text] [Related]
7. Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer.
Saito H; Osaki T; Ikeguchi M
Gastric Cancer; 2012 Jan; 15(1):27-33. PubMed ID: 21626292
[TBL] [Abstract][Full Text] [Related]
8. Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma.
Boroumand-Noughabi S; Sima HR; Ghaffarzadehgan K; Jafarzadeh M; Raziee HR; Hosseinnezhad H; Moaven O; Rajabi-Mashhadi MT; Azarian AA; Mashhadinejad M; Tavakkol-Afshari J
BMC Cancer; 2010 Jun; 10():275. PubMed ID: 20534173
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
10. Expression of Fas and Fas ligand in human gastric adenomas and intestinal-type carcinomas: correlation with proliferation and apoptosis.
Osaki M; Kase S; Kodani I; Watanabe M; Adachi H; Ito H
Gastric Cancer; 2001; 4(4):198-205. PubMed ID: 11846063
[TBL] [Abstract][Full Text] [Related]
11. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
12. The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response.
Liu H; Ubukata H; Tabuchi T; Nakachi T; Nagata H; Shimazaki J; Motohashi G; Konishi S; Nishimura M; Satani T; Hong J; Nakada I; Saniabadi AR; Tabuchi T
Mol Cell Biochem; 2009 Nov; 331(1-2):181-6. PubMed ID: 19458913
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach.
Kume T; Oshima K; Yamashita Y; Shirakusa T; Kikuchi M
Int J Cancer; 1999 Aug; 84(4):339-43. PubMed ID: 10404082
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer.
Ohno S; Tachibana M; Shibakita M; Dhar DK; Yoshimura H; Kinugasa S; Kubota H; Masunaga R; Nagasue N
Ann Surg Oncol; 2000 Dec; 7(10):750-7. PubMed ID: 11129423
[TBL] [Abstract][Full Text] [Related]
16. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues.
Li Q; Peng J; Li XH; Liu T; Liang QC; Zhang GY
World J Gastroenterol; 2010 Mar; 16(10):1274-8. PubMed ID: 20222173
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer.
Akagi J; Baba H
Int J Clin Oncol; 2008 Dec; 13(6):528-35. PubMed ID: 19093181
[TBL] [Abstract][Full Text] [Related]
20. Efficient recruitment of c-FLIP
Masuda A; Isobe Y; Sugimoto K; Yoshimori M; Arai A; Komatsu N
Cancer Sci; 2020 Mar; 111(3):807-816. PubMed ID: 31908105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]